Seres Therapeutics Stock Forecast

Sell candidate since Jun 02, 2026 Loss -18.55%

The Seres Therapeutics stock price gained 6.23% on the last trading day (Tuesday, 16th Jun 2026), rising from $5.62 to $5.97. During the last trading day the stock fluctuated 13.05% from a day low at $5.44 to a day high of $6.15. The price has fallen in 7 of the last 10 days and is down by -18.55% for this period. Volume fell on the last day by -72 thousand shares and in total, 79 thousand shares were bought and sold for approximately $474.15 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -27.64% during the next 3 months and, with a 90% probability hold a price between $4.03 and $5.28 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

MCRB Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 15, 2026, and so far it has risen 6.23%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Seres Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.10 and $7.26. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Seres Therapeutics stock

Seres Therapeutics finds support from accumulated volume at $5.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.710 between high and low, or 13.05%. For the last week the stock has had daily average volatility of 12.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MCRB) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Seres Therapeutics to open at $5.85, and during the day (based on 14 day Average True Range), to move between $5.65 and $6.29, which gives a possible trading interval of +/-$0.650 (+/-11.51%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 11.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.70 (4.52%) than the resistance at $6.63 (11.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Seres Therapeutics stock A Buy?

Seres Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.253 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $5.85 ( 1.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk